Sponsor-Initiated OCS Liver Perfusion (OLP-II) Registry

a study on Liver Transplant

Summary

Location
at La Jolla, California and other locations
Dates
study started
completion around
Principal Investigator
by Gabriel Schnickel, MD, MPH
Headshot of Gabriel Schnickel
Gabriel Schnickel

Description

Summary

OLP-II Registry is a sponsor-initiated, multi-center, observational, post-approval registry.

Details

The objective of the sponsor-initiated OLP-II Registry is to collect data on the post-transplant clinical outcomes of donor livers preserved and assessed on OCS Liver System and to document performance of the OCS device in the realworld setting.

Keywords

Liver Transplant, OCS Liver, OCS Liver Transplant Recipients

Eligibility

All liver transplant recipients who are transplanted with an OCS-perfused donor liver are eligible for the Registry.

Locations

  • University of California San Diego accepting new patients
    La Jolla California 92037 United States
  • Mayo Clinic Hospital Arizona accepting new patients
    Phoenix Arizona 85054 United States

Lead Scientist at UCSD

  • Gabriel Schnickel, MD, MPH
    Clinical Professor, Surgery, Vc-health Sciences-schools. Authored (or co-authored) 39 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
TransMedics
ID
NCT05940857
Study Type
Observational [Patient Registry]
Participants
Expecting 10000 study participants
Last Updated
Contact us about this trial